A. Sadek

Randomized open-label trial of intravenous brivaracetam versus lorazepam for acute treatment of increased seizure activity

J. Szaflarski, B. Moseley, A. Sadek, 2020, Epilepsy & Behavior.

Decoding Surface Fingerprints for Protein-Ligand Interactions

T. Blundell, P. Lio’, Freyr Sverrisson, 2022, bioRxiv.

Revisiting the specificity and ability of phospho-S129 antibodies to capture alpha-synuclein biochemical and pathological diversity

N. Guex, H. Lashuel, C. Iseli, 2022, npj Parkinson's Disease.

A randomized phase 2b efficacy study in patients with seizure episodes with a predictable pattern using Staccato® alprazolam for rapid seizure termination

J. French, V. Biton, M. Gelfand, 2022, Epilepsia.

Regional Cerebral Distribution of [Tc‐99m] Hexylmethylpropylene Amineoxine in Patients With Progressive Aphasia

A. Alavi, M. Grossman, A. Newberg, 2000, Journal of neuroimaging : official journal of the American Society of Neuroimaging.

Efficacy and Safety of Intravenous Brivaracetam as a Treatment for Increased Seizure Activity in an Epilepsy Monitoring Unit

J. Szaflarski, B. Moseley, A. Sadek, 2019, Epilepsy & Behavior.

Neighbouring modifications interfere with the detection of phosphorylated alpha-synuclein at Serine 129: Revisiting the specificity of pS129 antibodies

N. Guex, H. Lashuel, C. Iseli, 2022, bioRxiv.

Parkinsonism due to Manganism in a Welder

P. Schulz, R. Rauch, A. Sadek, 2003, International journal of toxicology.

Language comprehension and regional cerebral defects in frontotemporal degeneration and Alzheimer's disease

A. Alavi, M. D’Esposito, M. Grossman, 1998, Neurology.